FloBiotech Announces Agreement with UCLA Health® to Advance Neurodegenerative Disease TherapeuticsBASEL, Switzerland, June 09, 2026 (GLOBE NEWSWIRE) -- FloBiotech today announced an agreement with UCLA Health to advance a novel class of therapeutics targeting biologically validated protective pathways in neurodegeneration.
